Operating
Payment for contingent consideration liability (operating)
AbbVie Payment for contingent consideration liability (operating) increased by 6.0% to $722.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 31.5%, from $549.00M to $722.00M. Over 3 years (FY 2021 to FY 2025), Payment for contingent consideration liability (operating) shows an upward trend with a 215.8% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026May 8, 2026
How to read this metric
Consistent payments indicate that acquired businesses are successfully hitting growth or profitability targets.
Detailed definition
This represents the actual cash outflow made to satisfy contingent consideration obligations arising from business acqui...
Peer comparison
Comparable across firms that utilize earn-out structures in their M&A strategy.
Metric ID:
abbv_payment_contingent_consideration_operatingHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.75M | $22.75M | $22.75M | $3.00M | $14.00M | $2.00M | $391.00M | $463.00M | $391.00M | $485.00M | $580.00M | $539.00M | $549.00M | $859.00M | $776.00M | $681.00M | $722.00M |
| QoQ Change | — | +0.0% | +0.0% | -86.8% | +366.7% | -85.7% | >999% | +18.4% | -15.6% | +24.0% | +19.6% | -7.1% | +1.9% | +56.5% | -9.7% | -12.2% | +6.0% |
| YoY Change | — | — | — | -86.8% | — | — | — | >999% | >999% | >999% | +48.3% | +16.4% | +40.4% | +77.1% | +33.8% | +26.3% | +31.5% |
Range$2.00M – $859.00M
CAGR+137.3%
Avg YoY Growth>999%
Median YoY Growth+40.4%
Payment for contingent consideration liability (operating) at Other Companies
Frequently Asked Questions
- What is AbbVie's payment for contingent consideration liability (operating)?
- AbbVie (ABBV) reported payment for contingent consideration liability (operating) of $722.00M in Q1 2026.
- How has AbbVie's payment for contingent consideration liability (operating) changed year-over-year?
- AbbVie's payment for contingent consideration liability (operating) increased by 31.5% year-over-year, from $549.00M to $722.00M.
- What is the long-term trend for AbbVie's payment for contingent consideration liability (operating)?
- Over 3 years (2021 to 2025), AbbVie's payment for contingent consideration liability (operating) has grown at a 215.8% compound annual growth rate (CAGR), from $91.00M to $2.87B.
- What does payment for contingent consideration liability (operating) mean?
- Cash paid to sellers of acquired companies when performance targets are achieved.